FDA Inspection 813581 — Fresenius Kabi USA LLC

Fresenius Kabi USA LLC — FEI 1450022

The FDA completed an inspection of Fresenius Kabi USA LLC on January 18, 2013 in Melrose Park, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 18, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)